Evidence map›Paper›PMID 36851319›Full record

ArticleVaccines2023

Analysis of Antibodies Induced after SARS-CoV-2 Vaccination Using Antigen Coded Bead Array Luminex Technology.

Zixuan Song, Qizhi Luo, Ling Wan, Quan Zhu, Rongjiao Liu, Xiangli Yin, Xiaofang Lu, Leiyan Wei, Zhiqing Xiang, Yizhou Zou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Zixuan SongDepartment of Immunology, School of Basic Medical of Central South University, Changsha 410083, China.
Qizhi LuoDepartment of Immunology, School of Basic Medical of Central South University, Changsha 410083, China.
Ling WanDepartment of Immunology, School of Basic Medical of Central South University, Changsha 410083, China.
Quan ZhuDepartment of Immunology, School of Basic Medical of Central South University, Changsha 410083, China.
Rongjiao LiuDepartment of Immunology, School of Basic Medical of Central South University, Changsha 410083, China.
Xiangli YinDepartment of Immunology, School of Basic Medical of Central South University, Changsha 410083, China.
Xiaofang LuDepartment of Immunology, School of Basic Medical of Central South University, Changsha 410083, China.
Leiyan WeiDepartment of Immunology, School of Basic Medical of Central South University, Changsha 410083, China.
Zhiqing XiangDepartment of Immunology, School of Basic Medical of Central South University, Changsha 410083, China.
Yizhou ZouDepartment of Immunology, School of Basic Medical of Central South University, Changsha 410083, China.ORCID 0000-0002-9261-1161
Central South University · CN

Funding

National Natural Science Foundation of China 81873875National Natural Science Foundation of China 82171763
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BBIBP-CorVCoronaVacIgG assaySARS-CoV-2variants of concernZF2001

Identifiers

PMID36851319
PMCPMC9964277
OpenAlexW4320918408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.